0000899243-21-009963.txt : 20210304 0000899243-21-009963.hdr.sgml : 20210304 20210304192423 ACCESSION NUMBER: 0000899243-21-009963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210302 FILED AS OF DATE: 20210304 DATE AS OF CHANGE: 20210304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farwell Wildon CENTRAL INDEX KEY: 0001847941 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 21716008 MAIL ADDRESS: STREET 1: C/O DYNE THERAPEUTICS, INC. CITY: 830 WINTER STREET STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-02 0 0001818794 Dyne Therapeutics, Inc. DYN 0001847941 Farwell Wildon C/O DYNE THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 0 1 0 0 Chief Medical Officer Common Stock 2021-03-02 4 A 0 50000 0.00 A 50000 D Stock Option (right to buy) 17.77 2021-03-02 4 A 0 250000 0.00 A 2031-03-01 Common Stock 250000 250000 D Consists of shares of Common Stock issuable under 50,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on March 1, 2022. This option was granted on March 2, 2021. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on March 1, 2022 and the remaining shares vesting in equal quarterly installments thereafter. /s/ Richard Scalzo, Attorney-in-Fact 2021-03-04